Condition: Cardiac Arrest · Sponsor: AfterROSC
Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.
This description comes directly from the study's public registry record.
Jean Baptiste Lascarrou, MD, PhD · +33240087376 · jeanbaptiste.lascarrou@chu-nantes.fr
Alain Cariou, MD, PhD · alain.cariou@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU Nantes | Nantes, Pays de Loire, France | Recruiting |
| Hopital Jacques Cartier | Massy, France | Recruiting |
| Clinique Ambroise Paré | Neuilly-sur-Seine, France | Recruiting |
| APHP, Cochin | Paris, France | Recruiting |
| CH Versailles | Versailles, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05606809